<code id='48DBEFB237'></code><style id='48DBEFB237'></style>
    • <acronym id='48DBEFB237'></acronym>
      <center id='48DBEFB237'><center id='48DBEFB237'><tfoot id='48DBEFB237'></tfoot></center><abbr id='48DBEFB237'><dir id='48DBEFB237'><tfoot id='48DBEFB237'></tfoot><noframes id='48DBEFB237'>

    • <optgroup id='48DBEFB237'><strike id='48DBEFB237'><sup id='48DBEFB237'></sup></strike><code id='48DBEFB237'></code></optgroup>
        1. <b id='48DBEFB237'><label id='48DBEFB237'><select id='48DBEFB237'><dt id='48DBEFB237'><span id='48DBEFB237'></span></dt></select></label></b><u id='48DBEFB237'></u>
          <i id='48DBEFB237'><strike id='48DBEFB237'><tt id='48DBEFB237'><pre id='48DBEFB237'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          explore

          author:Wikipedia    - browse:98651
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore